Baidu
map

Acta Otolaryngol:流行性腮腺炎相关的听力损失的临床特性和诊断

2017-04-02 AlexYang MedSci原创

最近,研究人员就流行性腮腺炎引起的听力损失的临床特点以及评估听力结果状况进行了调查。研究人员利用可追溯的多单位的研究设计,分析了诊断为因流行性腮腺炎引起的病人听力损失的临床参数。研究单位有19家医院的耳鼻喉科门诊,时间段在1987年到2016年。研究人员将67位因流行性腮腺炎引起的听力损失病人作为研究群体。该研究群体包括了35名男性和32名女性,年龄从1岁到54岁。研究结果表明,63名病人表现出单

最近,研究人员就流行性腮腺炎引起的听力损失的临床特点以及评估听力结果状况进行了调查。研究人员利用可追溯的多单位的研究设计,分析了诊断为因流行性腮腺炎引起的病人听力损失的临床参数。研究单位有19家医院的耳鼻喉科门诊,时间段在1987年到2016年。

研究人员将67位因流行性腮腺炎引起的听力损失病人作为研究群体。该研究群体包括了35名男性和32名女性,年龄从1岁到54岁。研究结果表明,63名病人表现出单边性听力损失,4名病人表现为双边听力损失。另外,研究人员总共观察到了65只耳朵深度的听力损失,但只有1只有严重听力损失的耳朵表现了完全的恢复。更多的是,4名双边听力损失的病人接受了人工电子耳蜗外科手术,且大多数因流行性腮腺炎引起的听力损失的病人没有接种疫苗的历史。最后,研究结论指出,因流行性腮腺炎引起的大多数听力损失表现为单边深度的感觉神经听力损失,并且很难治疗。在稀有的彻底性双边耳聋案例中,人工电子耳蜗对语言的认知有利。研究人员推荐利用流行性腮腺炎疫苗来阻止流行性腮腺炎相关的听力损失

原始出处:

Morita S, Fujiwara K, Fukuda A et al. The clinical features and prognosis of mumps-associated hearing loss: a retrospective, multi-institutional investigation in Japan. Acta Otolaryngol. 24 March 2017. doi:10.1080/00016489.2017.1290826

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2017-10-01 tulenzi
  3. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2018-03-17 windight
  5. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2017-04-03 ysjykql
  7. [GetPortalCommentsPageByObjectIdResponse(id=2044932, encodeId=66852044932a4, content=<a href='/topic/show?id=3dd62288e2b' target=_blank style='color:#2F92EE;'>#临床特性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22887, encryptionId=3dd62288e2b, topicName=临床特性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Fri Jan 19 04:00:00 CST 2018, time=2018-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927303, encodeId=2c29192e30372, content=<a href='/topic/show?id=b95b653e389' target=_blank style='color:#2F92EE;'>#流行性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65373, encryptionId=b95b653e389, topicName=流行性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Sun Oct 01 17:00:00 CST 2017, time=2017-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1737264, encodeId=4a161e3726403, content=<a href='/topic/show?id=f5c38541851' target=_blank style='color:#2F92EE;'>#腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85418, encryptionId=f5c38541851, topicName=腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabe34270299, createdName=12498561m43(暂无昵称), createdTime=Mon May 22 14:00:00 CST 2017, time=2017-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849529, encodeId=8fcf1849529e5, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Mar 17 09:00:00 CST 2018, time=2018-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1967647, encodeId=ddbc196e64709, content=<a href='/topic/show?id=102e6538037' target=_blank style='color:#2F92EE;'>#流行性腮腺炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65380, encryptionId=102e6538037, topicName=流行性腮腺炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d40148, createdName=hyf028, createdTime=Fri Aug 18 23:00:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306056, encodeId=dd28130605688, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1361497, encodeId=9836136149ed0, content=<a href='/topic/show?id=41828541441' target=_blank style='color:#2F92EE;'>#腮腺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85414, encryptionId=41828541441, topicName=腮腺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Mon Apr 03 15:00:00 CST 2017, time=2017-04-03, status=1, ipAttribution=)]
    2017-04-03 mfx799
Baidu
map
Baidu
map
Baidu
map